当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析 - 资产负债表

以岭药业

(002603)

  

流通市值:194.69亿  总市值:236.24亿
流通股本:13.77亿   总股本:16.71亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金1,003,161,043.02853,034,839.38907,308,781.741,223,754,773.95
应收票据及应收账款1,607,442,791.611,225,430,236.422,778,342,773.442,749,902,737.02
应收账款1,607,442,791.611,225,430,236.422,778,342,773.442,749,902,737.02
应收款项融资463,374,984.89164,679,389.78309,275,555.81359,464,059.74
预付款项95,626,980.1552,771,323.79148,349,186.5139,821,766.74
其他应收款合计18,548,382.41129,849,796.0826,147,007.8210,348,016.22
存货1,385,508,236.241,746,380,345.141,940,905,922.511,917,473,001.84
其他流动资产57,705,915.88162,805,878.5364,245,435.29136,648,048.29
流动资产平衡项目0000
流动资产合计4,794,368,334.24,334,951,809.126,183,574,663.116,537,412,403.8
非流动资产:
长期股权投资2,467,765.172,470,541.62,473,669.452,475,740.87
其他非流动金融资产-1,000,0001,654,224,055.551,640,728,750.01
投资性房地产60,679,611.8162,556,648.7723,362,180.6823,848,899.72
固定资产5,913,931,139.036,011,503,000.75,943,728,874.875,940,508,866.36
在建工程1,186,954,728.841,196,940,326.891,360,710,102.691,342,088,187.19
生产性生物资产17,277,514.3816,126,842.324,678,433.316,014,703.27
使用权资产26,724,476.7527,987,315.723,783,360.6325,365,245.25
无形资产795,474,567.54802,570,427.18721,234,341.11728,737,426.93
开发支出270,129,783.3262,797,369.23216,741,614.94200,941,907.43
商誉107,953,261.39109,512,443.4111,071,625.41112,630,807.42
长期待摊费用4,471,713.034,080,492.24,709,763.663,148,675.04
递延所得税资产385,172,702.92365,836,675.85147,517,900.93163,931,928.28
其他非流动资产128,482,414.44120,837,195.32216,274,124.64223,692,658.54
非流动资产平衡项目0000
非流动资产合计8,899,719,678.68,984,219,279.1610,430,510,047.8710,414,113,796.31
资产平衡项目0000
资产总计13,694,088,012.813,319,171,088.2816,614,084,710.9816,951,526,200.11
流动负债:
短期借款--600,285,250460,257,250
应付票据及应付账款1,892,620,893.361,896,575,493.592,548,056,190.232,552,473,230.42
其中:应付票据126,070,429.1850,000,000592,562,046.78629,839,883.08
应付账款1,766,550,464.181,846,575,493.591,955,494,143.451,922,633,347.34
合同负债360,256,470.39272,337,042.06173,514,006.27272,849,117.72
应付职工薪酬249,092,045.2283,231,772.77206,079,385.46234,742,351.77
应交税费86,940,808.1576,383,315.7590,126,071.55104,251,989.37
其他应付款合计44,781,089.5748,476,089.14306,333,411.48535,536,060.99
应付股利--274,080,027.06501,211,612.8
一年内到期的非流动负债7,759,330.78,238,049.293,016,704.75203,689,476.84
其他流动负债19,702,442.2421,447,129.5610,342,292.5610,566,800.99
流动负债平衡项目0000
流动负债合计2,661,153,079.612,606,688,892.163,937,753,312.34,374,366,278.1
非流动负债:
长期借款--667,102,581.96598,395,160.99
租赁负债19,088,455.4818,212,904.5920,694,050.9421,748,513.01
递延收益374,960,088.28377,924,740.64375,591,062.28364,693,665.36
递延所得税负债112,692,703.17114,251,885.18127,301,379.82128,892,043.98
非流动负债平衡项目0000
非流动负债合计506,741,246.93510,389,530.411,190,689,0751,113,729,383.34
负债平衡项目0000
负债合计3,167,894,326.543,117,078,422.575,128,442,387.35,488,095,661.44
所有者权益(或股东权益):
实收资本(或股本)1,670,705,3761,670,705,3761,670,705,3761,670,705,376
资本公积2,342,780,896.142,342,780,896.142,342,780,896.142,342,780,896.14
其他综合收益-7,175,480.29-7,120,586.08-6,061,313.13-6,592,620.27
盈余公积936,762,403.7936,762,403.7936,762,403.7936,762,403.7
未分配利润5,606,312,938.765,280,359,642.516,559,652,068.166,535,332,333.9
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计10,549,386,134.3110,223,487,732.2711,503,839,430.8711,478,988,389.47
少数股东权益-23,192,448.05-21,395,066.56-18,197,107.19-15,557,850.8
股东权益平衡项目0000
股东权益合计10,526,193,686.2610,202,092,665.7111,485,642,323.6811,463,430,538.67
负债和股东权益合计13,694,088,012.813,319,171,088.2816,614,084,710.9816,951,526,200.11
公告日期2025-04-292025-04-292024-10-292024-08-28
审计意见(境内)标准无保留意见
TOP↑